FR 2021-03069

Overview

Title

National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table; Notice of Proposed Rulemaking; Public Comment Period; Delay of Effective Date

Agencies

ELI5 AI

The government is thinking about waiting a bit longer to start a new rule about vaccines that was supposed to begin soon, so people can share their thoughts and the rule can be looked at more closely. They want to make sure everything about the rule is good and fair before it starts.

Summary AI

In response to a Presidential directive from January 20, 2021, the Department of Health and Human Services (HHS) is proposing to delay the effective date of a new rule concerning the National Vaccine Injury Compensation Program until April 23, 2021. Originally set to take effect on February 22, 2021, the rule had been finalized on January 21, 2021, and involves changes to the Vaccine Injury Table. HHS seeks public comments on the proposed delay, which aims to provide more time to review the rule and address any possible legal, factual, or policy issues. Public comments must be submitted by February 16, 2021.

Abstract

In accordance with the Presidential directive as expressed in the memorandum of January 20, 2021, from the Assistant to the President and Chief of Staff, entitled "Regulatory Freeze Pending Review," this action proposes, following a brief public comment period, to further delay until April 23, 2021, the effective date of the rule entitled "National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table," published in the Federal Register on January 21, 2021. That final rule is scheduled to take effect on February 22, 2021. HHS seeks comments on this proposed delay, which would allow it additional opportunity for review and consideration of the new rule.

Citation: 86 FR 9308
Document #: 2021-03069
Date:
Volume: 86
Pages: 9308-9309

AnalysisAI

In response to a Presidential directive issued on January 20, 2021, the Department of Health and Human Services (HHS) is proposing to delay the implementation of a new rule related to the National Vaccine Injury Compensation Program. The rule, which was finalized on January 21, 2021, was originally set to take effect on February 22, 2021, but will now potentially see its effective date pushed back to April 23, 2021. The proposed delay aims to provide additional time for reviewing the rule and addressing any relevant legal, factual, or policy issues. The public has been invited to comment on this proposed delay, with a deadline for submissions set for February 16, 2021.

Summary of the Document

The document in question is a proposed rulemaking notice from the Health Resources and Services Administration, part of HHS. Following a memorandum from the President's Assistant Chief of Staff regarding a regulatory freeze, HHS is considering postponing the effective date of newly established rules to ensure they align with any new legal or policy requirements. This particular rule involves amendments to the Vaccine Injury Table, a component of the National Vaccine Injury Compensation Program. The rule has already undergone a finalization process, but the review will allow for potential reconsideration in light of the new administration's priorities.

Key Issues and Concerns

One primary concern raised by this document is the potential impact of the delay on individuals who were expecting changes to the Vaccine Injury Table to occur promptly. The delay could create uncertainty for those seeking compensation or clarity related to vaccine injuries. Additionally, the document mentions the removal of specific conditions, such as Shoulder Injury Related to Vaccine Administration and vasovagal syncope, but it lacks detailed reasoning for these removals and the potential implications for those affected by these conditions.

Further issues surface around the complexity of the legal citations and procedures involved. The reference to legal rulings and sections (e.g., 42 U.S.C. 300aa-14(c), 42 CFR 100.3) might challenge individuals unacquainted with legal jargon. This complexity may limit effective public participation or understanding, especially for stakeholders without a legal background.

Another consideration is the clarity surrounding the submission of public comments. The instructions provided may be perplexing for individuals unfamiliar with the Federal eRulemaking Portal. Moreover, instructions to avoid including "personally identifiable or confidential business information" without further clarification could lead to unnecessary caution or confusion.

Broader Public Impact

For the general public, particularly those who may be beneficiaries of the National Vaccine Injury Compensation Program, this proposed delay could have significant repercussions. It introduces an additional wait time that could disrupt expectations and planning for individuals anticipating eligibility changes due to the rule.

Impact on Specific Stakeholders

For stakeholders directly involved in managing vaccine injuries or advising on related compensations, this delay presents both a challenge and an opportunity. On one hand, the delay prolongs the certainty and implementation of the planned rule changes. On the other hand, it allows for a renewed chance to submit feedback or propose further revisions. Legal experts, healthcare providers, and affected individuals may all seek to ensure their comments are heard and considered during this extended review period.

Conclusion

Overall, while the proposed delay provides necessary time for reevaluation aligned with new presidential directives, it also raises several practical and procedural concerns. Stakeholders and affected individuals must navigate these complexities effectively to ensure their perspectives are included in the review process, and HHS can adequately assess the potential impacts of any revisions to the Vaccine Injury Table.

Issues

  • • The delay in the effective date of the rule may affect individuals expecting the previous revisions to the Vaccine Injury Table to be implemented. Clarity on the impact of this delay on stakeholders would be beneficial.

  • • The document mentions the removal of certain conditions from the Vaccine Injury Table, but does not provide detailed reasoning or potential impacts of these removals on individuals seeking compensation.

  • • Instructions for submitting comments might be unclear for individuals who are not familiar with the Federal eRulemaking Portal.

  • • The complexity of legal references (e.g., 42 U.S.C. 300aa-14(c), 42 CFR 100.3) might make it difficult for individuals without a legal background to fully understand the implications of the proposed rule.

  • • Potential confusion about what constitutes 'personally identifiable or confidential business information' that should not be included in public comments.

  • • The document assumes familiarity with federal rulemaking procedures, which might not be the case for all stakeholders, potentially limiting effective public participation.

Statistics

Size

Pages: 2
Words: 980
Sentences: 30
Entities: 81

Language

Nouns: 303
Verbs: 97
Adjectives: 49
Adverbs: 15
Numbers: 64

Complexity

Average Token Length:
5.33
Average Sentence Length:
32.67
Token Entropy:
5.18
Readability (ARI):
23.65

Reading Time

about 3 minutes